Market Overview

Sinclair Research Appoints Scott Boley as Vice President of Toxicology

Share:

Sinclair
Research
, one of the nation's leading providers of nonclinical
services, has named Scott
E. Boley
, PhD, DABT, as vice president of toxicology. In this newly
created role, he will have overall responsibility for driving the growth
of Sinclair's toxicology efforts and fostering relationships with new
and current customers.

Dr. Boley became a board-certified toxicologist in 2003, and has
extensive expertise in drug development as well as the regulatory
expectations for a variety of test article types and indications. He
will be applying his breadth of experience to benefit Sinclair customers.

"Scott is an experienced toxicologist who is well-known in the
industry," said Guy Bouchard, DVM, president of Sinclair Research
Center. "He is an expert in compound safety assessment with a deep
regulatory understanding. Scott has advised sponsors with compound
safety regulatory needs for the last 13 years and managed toxicology
programs for 17 years. He will be an asset to our clients and their
consultants."

Scott joins Sinclair Research from MPI Research in Mattawan, Mich. He
joined MPI in 2005 as a study director in general toxicology and was
promoted to senior director of general toxicology and infusion. For the
last four years, he served as senior scientific advisor working with the
business development arm of MPI, assisting sponsors in evaluating which
nonclinical studies they needed for their test article. Prior to MPI,
Boley worked at Eli Lilly and Company where he was the toxicology lead
on development teams for novel therapeutics designing, implementing, and
overseeing nonclinical safety studies.

About Sinclair Research
Sinclair
Research Center
, a preclinical contract research organization (CRO)
established in 1964, offers animal efficacy models, IND enabling
toxicology services and research capabilities to animal health and
medical device companies. Our clients include large, mid-tier, small and
startup companies in both human and animal health markets. With more
than 50 years' experience, Sinclair is the undisputed expert in all
breeds of miniature swine. In addition, we manage many standing animal
colony models including diabetes, wound healing, irritable bowel disease
and general PK, and we have developed and maintain our own unique
research breed of mini-swine, "The Sinclair Pig."

View Comments and Join the Discussion!